Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Tesla Recalling Almost 54,000 Vehicles Over Full Self-Driving Beta Software 'Rolling-Stop' Feature

Tesla, Inc. (NASDAQ: TSLA) could be facing a setback with its full-self driving software that is currently in beta testing.

Benzinga

34 Stocks Moving In Tuesday's Mid-Day Session

Gainers Biofrontera Inc. (NASDAQ: BFRI) shares climbed 30.7% to $4.4095 after the company provided an update on patient recruitment for the Phase III study for the treatment of sBCC with Ameluz-PDT.

Benzinga

Coinbase Q4 Retail Activity Boosted By Shiba Inu's October Rally: Is Robinhood Missing Out?

Coinbase Global, Inc.'s (NASDAQ: COIN) fourth-quarter results may have benefited from strong retail trading volume, according to an analyst at Needham.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Premier's Q2 Sales Decline On Lower Demand For PPE Kits, Issues Mixed FY22 Outlook

Premier Inc (NASDAQ: PINC) has reported

Benzinga

12 Information Technology Stocks Moving In Tuesday's Intraday Session

Benzinga

Will AMD Recover And Hit New All-Time High Following Q4 Results? This Analyst Thinks So

Advanced Micro Devices Inc (NASDAQ: AMD) is scheduled to report its fourth-quarter results Tuesday after the close.

Benzinga

If You Invested $1,000 In Each Of The FAANG Stocks One Year Ago, Here's How Much You'd Have Now

Despite ongoing concerns about COVID-19, inflation, supply chain disruptions and rising interest rates, the Nasdaq is still trading more than 110% above its March 2020 lows.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Attention Biotech Investors: Mark Your Calendar For These Key February PDUFA Dates

After a fairly robust 2021, the new year started on a mixed note as far as regulatory decisions are concerned.

Benzinga

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

Here's a roundup of top developments in the biotech space over the last 24 hours:

Benzinga

10 Biggest Price Target Changes For Tuesday

Baird cut the price target on Tabula Rasa HealthCare, Inc. (NASDAQ: TRHC) from $24 to $11. Tabula Rasa HealthCare shares fell 2% to $10.57 in pre-market trading.

Benzinga

Cathie Wood Loads Up In These 3 Crypto-Linked Stocks On Monday

Cathie Wood-led Ark Investment Management on Monday loaded up more shares in Robinhood Markets Inc (NASDAQ: HOOD), Coinbase Global Inc (NASDAQ: COIN) and Block

Benzinga

Executives Buy More Than $600M Of 3 Stocks

Although US stocks closed sharply higher in the last trading session of January, but the S&P 500 and Nasdaq still recorded their worst months since March 2020. Investors, meanwhile, focused on some notable insider trades.

Benzinga

Sony-Bungie, Microsoft-Activision: Analysts Think This Is Just The Beginning Of A M&A Spree In The Gaming Industry

Loup Funds analysts Gene Munster and Doug Clinton said during a discussion Monday that there is a build-up of urgency around the acquisition of gaming content after a recent flurry of mergers and acquisitions.

Benzinga

A Peek Into The Markets: US Stock Futures Edge Lower Following Monday's Surge; Alphabet Earnings in Focus

Pre-open movers

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

64 Biggest Movers From Yesterday

Gainers

Benzinga

Nio Soars As ET5 Prototype Rolls Out: A Technical Look At The Stock

Nio, Inc (NYSE: NIO) was soaring over 17% higher intraday on Monday in unison with Tesla, Inc (NASDAQ: TSLA), which was shooting up about 10%.

Benzinga

Is Novavax Turning Around? A Technical Analysis

Novavax, Inc. (NASDAQ: NVAX) shares are trading higher Monday after the company submitted a request to the U.S Food and Drug Administration for Emergency Use Authorization of its COVID-19 vaccine, NVX-CoV2373. Novavax was up 13% at $93.70 Monday afternoon at publication.

Benzinga

EXCLUSIVE: HotelPlanner CEO Tim Hentschel On The Transition To Becoming Publicly Traded

One of the next companies to enact the transition from privately-held to publicly-traded is HotelPlanner, the West Palm Beach, Florida-based travel technology company that provides online services in the global group hotel marketplace.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

AmpliTech CEO Provides Update: All You Need To Know

AmpliTech Group Inc (NASDAQ:AMPG) CEO Fawad Maqbool disclosed a backlog of $10.5 million in orders likely to ship principally in the first half of 2022, versus revenue of $3.5 million in the twelve months ended September 30, 2021. Maqbool said it provides an excellent revenue base via new solutions and expanded sales and…

Benzinga

Mid-Afternoon Market Update: Nasdaq Jumps 375 Points; Imperial Petroleum Shares Drop

US stocks recorded gains on the final trading day of January, with the Nasdaq Composite surging more than 350 points on Monday.

Benzinga

Why Bitcoin- And Ethereum-Related Stocks Are Rising Today

Shares of crypto-related stocks, including Marathon Digital Holdings, Inc. (NASDAQ: MARA), Riot Blockchain, Inc. (NASDAQ: RIOT) and Coinbase Global, Inc. (NASDAQ:

Benzinga

Why Shopify CEO Tobi Lütke Is Joining The Coinbase Board

Coinbase Global Inc. (NASDAQ: COIN) recently added the CEO of one of the largest e-commerce brands to its board.

Benzinga

32 Stocks Moving In Monday's Mid-Day Session

Gainers FGI Industries Ltd. (NASDAQ: FGI) shares jumped 42.4% to $5.37 after surging 19% on Friday. The company, last week, priced its IPO at $6 per share.

Benzinga

NRx Pharmaceuticals Raises $25M Via Equity To Support Its Pipeline Development

NRx Pharmaceuticals (NASDAQ: NRXP) has announced the private placement of 7.8 million shares priced at a premium to market under Nasdaq rule, for

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For January 31, 2022

Upgrades

1 … 828 829 830 831

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.